Suzuken Co. Ltd.

Pharmaceuticals
Japan
Executive 1Yoshiki Bessho, Chairman; | Chairman;
Executive 2Hiroshi Ota, President; | President;
Earnings Per Share Growth (%)N/A
Cost of Goods Sold (US$ Millions)$15,104
Current Liabilities (US$ Millions)$5,876
Total Assets (US$ Millions)$6,522
Long Term Debt (Millions)$4
Return on Equity7.18%
Revenue (US$ Millions)$16,664
Total Company Assets$8,609
Revenue Growth (%)4.94%
Net Income (US$ Millions)$180
Earnings Per Share (US$)N/A
Total Equity (US$ Millions)$2,644
Profit Margin (%)1.08%
Debt To Equity Ratio (%)0.00%
Inventories (Millions)$1,341